{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:31:03Z","timestamp":1790839863595,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine whether maternal peak bile acids (BA) and aminotransferases predict adverse perinatal outcomes, particularly preterm birth, in hospitalized patients with intrahepatic cholestasis of pregnancy (ICP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 179 singleton pregnancies complicated by ICP. Patients were stratified according to peak BA levels (&lt;\u200940 vs.\u2009\u2265\u200940 \u00b5mol\/L) and ALT categories (\u2264\u200925, 25\u2013125, &gt;\u2009125 IU\/L). The primary outcome was preterm birth (&lt;\u200937 weeks). Secondary outcomes included fetal distress, meconium-stained amniotic fluid, NICU admission, gestational age at diagnosis and delivery, birth weight, and length of hospitalization. Receiver operating characteristic (ROC) analyses were performed to evaluate the discriminatory ability of laboratory parameters, and multivariable logistic regression analysis was used to identify independent predictors of preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Preterm birth occurred in 27.4% of pregnancies (49\/179). BA\u2009\u2265\u200940 \u00b5mol\/L was associated with earlier diagnosis and delivery and longer hospitalization. Increasing ALT categories were associated with earlier diagnosis and delivery, longer hospitalization, and lower birth weight. ALT showed the highest discriminatory performance for predicting preterm birth (AUC 0.70), followed by AST and BA (AUC 0.68 for both). In multivariable analysis, BA\u2009\u2265\u200940 \u00b5mol\/L and ALT\u2009&gt;\u2009125 IU\/L remained independently associated with preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In hospitalized patients with ICP, elevated bile acid and ALT levels are independently associated with an increased risk of preterm birth. Combined evaluation of bile acids and aminotransferases may improve risk stratification and support individualized surveillance and delivery planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09064-7","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:55:37Z","timestamp":1776300937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of perinatal outcomes in intrahepatic cholestasis of pregnancy in relation to transaminase and bile acid levels"],"prefix":"10.1186","volume":"26","author":[{"given":"Mine G\u00fcltekin","family":"\u00c7al\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge Y\u00fccel","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"K\u00f6ksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aykan","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"13","key":"9064_CR1","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1111\/1471-0528.17206","volume":"129","author":"J Girling","year":"2022","unstructured":"Girling J, et al. Intrahepatic cholestasis of pregnancy: Green-top Guideline 43. BJOG. 2022;129(13):e95\u2013114. https:\/\/doi.org\/10.1111\/1471-0528.17206.","journal-title":"BJOG"},{"issue":"2","key":"9064_CR2","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2020.11.002","volume":"224","author":"RH Lee","year":"2021","unstructured":"Lee RH, et al. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2021;224(2):B2\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2020.11.002.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"9064_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/1471-0528.16567","volume":"128","author":"J Fleminger","year":"2021","unstructured":"Fleminger J, Seed PT, Smith A, Juszczak E, Dixon PH, Chambers J, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial. BJOG. 2021;128(6):1066\u201375. https:\/\/doi.org\/10.1111\/1471-0528.16567.","journal-title":"BJOG"},{"issue":"10201","key":"9064_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019;394(10201):849\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(19)31270-X.","journal-title":"Lancet"},{"issue":"2","key":"9064_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cld.2021.01.007","volume":"25","author":"C Ovadia","year":"2021","unstructured":"Ovadia C, Williamson C. Intrahepatic cholestasis of pregnancy: recent advances. Clin Liver Dis. 2021;25(2):305\u201326. https:\/\/doi.org\/10.1016\/j.cld.2021.01.007.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"9064_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/AOG.0000000000001194","volume":"127","author":"C Williamson","year":"2016","unstructured":"Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2016;127(1):120\u201333. https:\/\/doi.org\/10.1097\/AOG.0000000000001194.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"9064_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2468-1253(21)00074-1","volume":"6","author":"C Ovadia","year":"2021","unstructured":"Ovadia C, Seed PT, Williamson C. Bile acids and adverse fetal outcomes in intrahepatic cholestasis of pregnancy: systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(7):547\u201358. https:\/\/doi.org\/10.1016\/S2468-1253(21)00074-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"9064_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.12669\/pjms.322.9057","volume":"32","author":"A Ekiz","year":"2016","unstructured":"Ekiz A, Kaya B, Avci ME, Polat I, Dikmen S, Yildirim G. Alanine aminotransferase as a predictor of adverse perinatal outcomes in women with intrahepatic cholestasis of pregnancy. Pak J Med Sci. 2016;32(2):418\u201322. https:\/\/doi.org\/10.12669\/pjms.322.9057.","journal-title":"Pak J Med Sci"},{"issue":"3","key":"9064_CR9","doi-asserted-by":"publisher","first-page":"e4531","DOI":"10.1016\/j.ajog.2023.06.036","volume":"229","author":"ML Estin","year":"2023","unstructured":"Estin ML, Campbell AIK, Watkins VY, Dotters-Katz SK, Brady CW, Federspiel JJ. Risk of stillbirth in United States patients with diagnosed intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2023;229(3):e4531\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2023.06.036.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"9064_CR10","doi-asserted-by":"publisher","first-page":"100897","DOI":"10.1016\/j.ajogmf.2023.100897","volume":"5","author":"T Zhan","year":"2023","unstructured":"Zhan T, et al. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(5):100897. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100897.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10174","key":"9064_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: individual patient data meta-analysis. Lancet. 2019;393(10174):899\u2013909. https:\/\/doi.org\/10.1016\/S0140-6736(18)31877-4.","journal-title":"Lancet"},{"issue":"9","key":"9064_CR12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/jog.13399","volume":"43","author":"D Cui","year":"2017","unstructured":"Cui D, Zhong Y, Zhang L, Du H. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2017;43(9):1411\u201320. https:\/\/doi.org\/10.1111\/jog.13399.","journal-title":"J Obstet Gynaecol Res"},{"issue":"8","key":"9064_CR13","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.jogc.2024.102618","volume":"46","author":"SR Hobson","year":"2024","unstructured":"Hobson SR, Cohen ER, Gandhi S, Jain V, Niles KM, Roy-Lacroix M-\u00c8, et al. Guideline 452: diagnosis and management of intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Can. 2024;46(8):102618. https:\/\/doi.org\/10.1016\/j.jogc.2024.102618.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"9064_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/01443615.2014.968102","volume":"35","author":"R Madazli","year":"2015","unstructured":"Madazli R, Yuksel MA, Oncul M, Tuten A, Guralp O, Aydin B. Pregnancy outcomes and prognostic factors in patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol. 2015;35(4):358\u201361. https:\/\/doi.org\/10.3109\/01443615.2014.968102.","journal-title":"J Obstet Gynaecol"},{"issue":"46","key":"9064_CR15","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.3748\/wjg.v13.i46.6226","volume":"13","author":"J Kondrackiene","year":"2007","unstructured":"Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2007;13(46):6226\u201330. https:\/\/doi.org\/10.3748\/wjg.v13.i46.6226.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"9064_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467\u201374. https:\/\/doi.org\/10.1002\/hep.20336.","journal-title":"Hepatology"},{"issue":"3","key":"9064_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-0028-1085099","volume":"28","author":"H Reyes","year":"2008","unstructured":"Reyes H. Intrahepatic cholestasis of pregnancy: a puzzling disorder of pregnancy. Semin Liver Dis. 2008;28(3):254\u201361. https:\/\/doi.org\/10.1055\/s-0028-1085099.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"9064_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ajo.13719","volume":"63","author":"WM Hague","year":"2023","unstructured":"Hague WM, et al. Intrahepatic cholestasis of pregnancy\u2014Diagnosis and management: a consensus statement (executive summary). Aust N Z J Obstet Gynaecol. 2023;63(5):656\u201365. https:\/\/doi.org\/10.1111\/ajo.13719.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"13","key":"9064_CR19","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/1471-0528.17199","volume":"128","author":"AL Mitchell","year":"2021","unstructured":"Mitchell AL, Ovadia C, Syngelaki A, et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case\u2013control and cohort study. BJOG. 2021;128(13):1635\u201344. https:\/\/doi.org\/10.1111\/1471-0528.17199.","journal-title":"BJOG"},{"key":"9064_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s12884-024-06645-2","volume":"24","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Zhang X, Liu Y, et al. Relationship between serum bile acid levels and adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: a retrospective cohort study. BMC Pregnancy Childbirth. 2024;24:645. https:\/\/doi.org\/10.1186\/s12884-024-06645-2.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"15","key":"9064_CR21","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.3390\/jcm11154378","volume":"11","author":"Y Bacq","year":"2022","unstructured":"Bacq Y, Sentilhes L, Reyes HB, et al. Evolving concepts in intrahepatic cholestasis of pregnancy: risk stratification and limitations of biochemical thresholds. J Clin Med. 2022;11(15):4378. https:\/\/doi.org\/10.3390\/jcm11154378.","journal-title":"J Clin Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09064-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:08:02Z","timestamp":1781647682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09064-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9064"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09064-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee of Etlik Z\u00fcbeyde Han\u0131m Gynecology and Obstetrics Training and Research Hospital, Ankara, T\u00fcrkiye.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was waived by the Ethics Committee of Etlik Z\u00fcbeyde Han\u0131m Gynecology and Obstetrics Training and Research Hospital due to the retrospective design of the study and the use of anonymized clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}